PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40052195,Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder.,2025,Kira D HÃ¶ffler,Dr. Einar Martens Research Group for Biological Psychiatry,N/A
40051583,"Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.",2024,"Ben Medrano, Randall Scharlach","Nue Life Medical Group, Field Trip Medical Inc.",N/A
40051276,A plain language summary of results from the FLAURA2 study: Effects of initial (first-line) osimertinib plus chemotherapy on the brain in patients with EGFR-mutated advanced non-small cell lung cancer.,2025,David Planchard,Thoracic Group and International Center for Thoracic Cancers (CICT),N/A
40042435,Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.,2025,"Daniela Pellegrino, Alexander Arkhipenko, Alexis Moscoso Rial","Pharmaceutical Diagnostics, Pharmaceutical Diagnostics, Nuclear Medicine Department and Molecular Imaging Group",N/A
40038800,Improving vulnerable Calbindin1,2025,Jian-Zhi Wang,Co-innovation Center of Neuroregeneration,wangjz@mail.hust.edu.cn
40037166,Evaluating cardiac function in ex vivo heart perfusion using lumped parameter models.,2025,Doug Vincent,Ventriflo Inc.,frikhtegarnezami@bwh.harvard.edu
